halobetasol propionate and tazarotene

FDA Drug Profile — Duobrii

Drug Details

Generic Name
halobetasol propionate and tazarotene
Brand Names
Duobrii
Application Number
NDA209354
Sponsor
Bausch Health US, LLC
NDC Codes
1
Dosage Forms
LOTION
Routes
TOPICAL
Active Ingredients
HALOBETASOL PROPIONATE, TAZAROTENE

Indications and Usage

1 INDICATIONS AND USAGE DUOBRII ® (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% is indicated for the topical treatment of plaque psoriasis in adults. DUOBRII Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults. ( 1 )